• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗感染的靶向纳米药物。

Targeted nanomedicines for the treatment of infection.

作者信息

Wang Shi, Ding Hao, Li Longsong, Zhao Ruifang, Chai Ningli

机构信息

Department of Gastroenterology, The First Medical Center of Chinese PLA General Hospital, Beijing, 100853, PR China.

Graduate School of the People's Liberation Army (PLA) General Hospital, Beijing, 100853, PR China.

出版信息

Mater Today Bio. 2025 Apr 30;32:101820. doi: 10.1016/j.mtbio.2025.101820. eCollection 2025 Jun.

DOI:10.1016/j.mtbio.2025.101820
PMID:40458694
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12127871/
Abstract

is a significant risk factor for gastric cancer, making its elimination crucial for prevention. This review explores the application of nanotechnology in enhancing treatment efficacy against and addressing antibiotic resistance. Nanomaterials are utilized as drug carriers to protect pharmaceuticals from the acidic gastric environment and enable controlled release. These materials can be specifically engineered to target surface molecules, thereby improving antimicrobial efficacy. Enhanced drug penetration is achieved by optimizing the surface properties and molecular architecture of nanomaterials. Additional strategies include targeting virulence factors, such as urease and vacuolating cytotoxin A, as well as inhibiting bacterial proliferation through reactive oxygen species-based therapies. Moreover, the ability of nanomaterials to effectively modulate the microbiota and inhibit pathogens has shown great potential in the application of combating . By focusing on specific invasion mechanisms and metabolic pathways, nanotechnology offers significant promise for advancing treatments against . Despite its potential, several challenges remain, including high drug development costs, difficulties in precise targeting, and adverse effects associated with certain approaches, such as photothermal therapy. Ongoing optimization of nanotechnological strategies is anticipated to address these challenges, thereby facilitating the development of more effective and targeted therapies for infection.

摘要

是胃癌的一个重要风险因素,因此消除它对于预防胃癌至关重要。本综述探讨了纳米技术在提高针对的治疗效果和解决抗生素耐药性方面的应用。纳米材料被用作药物载体,以保护药物免受酸性胃环境的影响并实现控释。这些材料可以经过特殊设计以靶向表面分子,从而提高抗菌效果。通过优化纳米材料的表面性质和分子结构来实现增强的药物渗透。其他策略包括靶向毒力因子,如尿素酶和空泡毒素A,以及通过基于活性氧的疗法抑制细菌增殖。此外,纳米材料有效调节微生物群和抑制病原体的能力在对抗的应用中显示出巨大潜力。通过关注特定的入侵机制和代谢途径,纳米技术在推进针对的治疗方面具有重大前景。尽管具有潜力,但仍存在一些挑战,包括药物开发成本高、精确靶向困难以及与某些方法(如光热疗法)相关的不良反应。预计对纳米技术策略的持续优化将解决这些挑战,从而促进开发更有效和有针对性的治疗感染的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/db347da6961c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/39e9fd77a3f5/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/2b1cc54dcc75/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/27e6e84117c9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/d5fcea5cef9a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/db347da6961c/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/39e9fd77a3f5/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/2b1cc54dcc75/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/27e6e84117c9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/d5fcea5cef9a/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ec4/12127871/db347da6961c/gr4.jpg

相似文献

1
Targeted nanomedicines for the treatment of infection.用于治疗感染的靶向纳米药物。
Mater Today Bio. 2025 Apr 30;32:101820. doi: 10.1016/j.mtbio.2025.101820. eCollection 2025 Jun.
2
Anti-urease therapy: a targeted approach to mitigating antibiotic resistance in Helicobacter pylori while preserving the gut microflora.抗脲酶疗法:一种在保留肠道微生物群的同时减轻幽门螺杆菌抗生素耐药性的靶向方法。
Gut Pathog. 2025 May 28;17(1):37. doi: 10.1186/s13099-025-00708-1.
3
Nanomedicine for the eradication of : recent advances, challenges and future perspective.纳米医学在根除方面的应用:最新进展、挑战与未来展望。
Future Microbiol. 2024 Mar;19:431-447. doi: 10.2217/fmb-2023-0189. Epub 2024 Feb 21.
4
Combatting with oral nanomedicines.对抗口服纳米药物。
J Mater Chem B. 2021 Dec 15;9(48):9826-9838. doi: 10.1039/d1tb02038b.
5
Novel Drug Delivery Systems for Combating : A Brief Review.用于对抗的新型药物递送系统:简要综述。
Arch Razi Inst. 2024 Oct 31;79(5):903-914. doi: 10.32592/ARI.2024.79.5.903. eCollection 2024 Oct.
6
Combatting Helicobacter pylori: A Focus on Nanomaterials.对抗幽门螺杆菌:聚焦纳米材料
Helicobacter. 2024 Nov-Dec;29(6):e70004. doi: 10.1111/hel.70004.
7
The role of miRNAs in pathogenesis, diagnosis, and therapy of Helicobacter pylori infection, gastric cancer-causing bacteria: Special highlights on nanotechnology-based therapy.微小RNA在幽门螺杆菌感染(一种导致胃癌的细菌感染)的发病机制、诊断及治疗中的作用:基于纳米技术治疗的特别亮点
Microb Pathog. 2025 Aug;205:107646. doi: 10.1016/j.micpath.2025.107646. Epub 2025 May 8.
8
Phellodendron chinense C.K.Schneid: An in vitro study on its anti-Helicobacter pylori effect.中国黄柏:其抗幽门螺杆菌作用的体外研究
J Ethnopharmacol. 2024 Oct 28;333:118396. doi: 10.1016/j.jep.2024.118396. Epub 2024 May 31.
9
Future Nanotechnology-Based Strategies for Improved Management of Helicobacter pylori Infection.基于纳米技术的未来策略,改善幽门螺杆菌感染的管理。
Small. 2024 Jan;20(3):e2302532. doi: 10.1002/smll.202302532. Epub 2023 Sep 11.
10
Nanomaterials: A Prospective Strategy for Biofilm-Forming Treatment.纳米材料:一种用于生物膜形成治疗的前瞻性策略。
Int J Nanomedicine. 2025 Apr 23;20:5209-5229. doi: 10.2147/IJN.S512066. eCollection 2025.

本文引用的文献

1
Ecological dynamics of Enterobacteriaceae in the human gut microbiome across global populations.全球人群肠道微生物群中肠杆菌科的生态动力学
Nat Microbiol. 2025 Feb;10(2):541-553. doi: 10.1038/s41564-024-01912-6. Epub 2025 Jan 10.
2
Aptamer and DNAzyme Based Colorimetric Biosensors for Pathogen Detection.基于适配体和脱氧核酶的比色生物传感器用于病原体检测
Angew Chem Int Ed Engl. 2025 Jan 21;64(4):e202418725. doi: 10.1002/anie.202418725. Epub 2024 Nov 25.
3
Commensal consortia decolonize Enterobacteriaceae via ecological control.
共生联合体通过生态控制使肠杆菌科去殖民化。
Nature. 2024 Sep;633(8031):878-886. doi: 10.1038/s41586-024-07960-6. Epub 2024 Sep 18.
4
An antibiotic-free platform for eliminating persistent infection without disrupting gut microbiota.一个无抗生素平台,用于消除持续性感染而不破坏肠道微生物群。
Acta Pharm Sin B. 2024 Jul;14(7):3184-3204. doi: 10.1016/j.apsb.2024.03.014. Epub 2024 Mar 10.
5
Cascaded Nanozyme Based pH-Responsive Oxygenation for Targeted Eradication of Resistant Helicobacter Pylori.基于级联纳米酶的 pH 响应性氧合作用用于靶向根除耐药性幽门螺杆菌。
Small. 2024 Sep;20(36):e2401059. doi: 10.1002/smll.202401059. Epub 2024 May 22.
6
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
7
A nanoparticle-based sonodynamic therapy reduces Helicobacter pylori infection in mouse without disrupting gut microbiota.基于纳米颗粒的声动力学疗法可减少小鼠幽门螺杆菌感染而不破坏肠道微生物群。
Nat Commun. 2024 Jan 29;15(1):844. doi: 10.1038/s41467-024-45156-8.
8
Mucus-Penetrating Nanoassembly as Potential Oral Phototherapeutic Formulation against Multi-Drug Resistant Helicobacter pylori Infection.作为抗多重耐药幽门螺杆菌感染潜在口服光疗制剂的黏液穿透性纳米组装体
Small. 2024 May;20(20):e2306909. doi: 10.1002/smll.202306909. Epub 2023 Dec 15.
9
Dual-Targeted Graphitic Cascade Nanozymes for Recognition and Treatment of Helicobacter pylori.双靶向石墨化级联纳米酶用于幽门螺杆菌的识别与治疗。
Small. 2024 Apr;20(14):e2306155. doi: 10.1002/smll.202306155. Epub 2023 Nov 22.
10
Nanoprobiotics for Remolding the Pro-inflammatory Microenvironment and Microbiome in the Treatment of Colitis.纳米益生菌重塑促炎微环境和微生物群用于治疗结肠炎
Nano Lett. 2023 Sep 27;23(18):8593-8601. doi: 10.1021/acs.nanolett.3c02408. Epub 2023 Aug 25.